Amdocs Limited DOX
Set alert
62.00 USD -1.54 -2.42%
As of Nov 3, 2:38 PM ET
61.67 Day range 62.95
49.74 52-week range 85.63
- YTD
- -22.99%
- 1 year
- -26.30%
- Open
- 62.53
- Prev close
- 63.54
- Mkt cap
- 6.48B
- Vol
- 481.33K
- Avg vol
- 1.03M
- EPS
- 4.21
- P/E
- 14.74
- Div yield
- 3.66%
More statistics
- Low
- 61.67
- High
- 62.95
- Forward P/E
- 7.91
- Beta
- 0.41
- Short ratio
- 8.77
- Inst. own
- 104.80%
- Dividend
- 2.28
- Ex-div date
- Sep 29, 2026
- Earnings
- Nov 10, 2026
- 50-d avg
- 60.60
- 200-d avg
- 62.60
- 1y target
- 79.25
Analyst view
Price target (mean) 79.25 +27.8% upside
Now 62.00
- Target (low)
- 63.00
- Target (mean)
- 79.25
- Target (high)
- 105.00
Ratings (0m) 6 3 buy · 3 hold · 0 sell
- Strong buy0
- Buy3
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.98 | 1.96 – 2.01 | 1.83 | +8.1% | 1.19B | +3.9% | 5 |
| Next quarter | 1.93 | 1.91 – 1.96 | 1.81 | +6.8% | 1.20B | +3.8% | 4 |
| Current year | 7.42 | 7.40 – 7.45 | 6.99 | +6.2% | 4.70B | +3.7% | 6 |
| Next year | 8.03 | 7.83 – 8.29 | 7.42 | +8.2% | 4.85B | +3.2% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 29, 2026 | Keybanc | Initiated | — | Sector Weight |
| May 14, 2026 | Stifel | Maintained | Buy | Buy |
| Feb 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 4, 2026 | Stifel | Maintained | Buy | Buy |
| Nov 13, 2025 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Nov 12, 2025 | Stifel | Maintained | Buy | Buy |
| Nov 12, 2025 | B of A Securities | Maintained | Buy | Buy |
| Jul 8, 2025 | Wolfe Research | Initiated | — | Outperform |
| Nov 14, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 13, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 2, 2024 | Stifel | Initiated | — | Buy |
| May 9, 2024 | Citigroup | Maintained | Buy | Buy |
| May 9, 2024 | Baird | Maintained | Neutral | Neutral |
| Feb 8, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jan 17, 2024 | Citigroup | Maintained | Buy | Buy |
| Dec 1, 2023 | Jefferies | Initiated | — | Buy |
| Aug 3, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| May 16, 2023 | Barclays | Upgrade | Equal-Weight | Overweight |
| May 11, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Feb 2, 2023 | Baird | Maintained | — | Neutral |
| Feb 1, 2023 | Oppenheimer | Maintained | — | Outperform |
| Nov 9, 2022 | Citigroup | Maintained | — | Buy |
| Aug 4, 2022 | Barclays | Maintained | — | Equal-Weight |
| Aug 4, 2022 | Citigroup | Maintained | — | Buy |
| May 12, 2022 | Citigroup | Maintained | — | Buy |
| Dec 14, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 5, 2021 | Oppenheimer | Maintained | — | Outperform |
| Nov 11, 2020 | JP Morgan | Upgrade | Neutral | Overweight |
| May 11, 2020 | Citigroup | Maintained | — | Buy |
| Feb 5, 2020 | Baird | Maintained | — | Neutral |